Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03527264
Title BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Don Dizon
Indications

cervical cancer

Therapies

Cisplatin + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.